Question normal

What parameter or evidence was used to measure outcomes at day 21?
Given the complexity of SARS Cov-2 infection and the severity of some pulmonary thromboembolism, have you planned longer-term follow-up of your study patients?
Perhaps at 28 days during hospitalization, or follow-up at 1, 2, 3 months at discharge could any difference be found in critically ill patients?